Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Clinuvel Europe Limited

Clinical trials sponsored by Clinuvel Europe Limited, explained in plain language.

Now part of Clinuvel Pharmaceuticals Limited CUV ASX

European subsidiary of Clinuvel, a biopharmaceutical company focused on skin disorders.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

EPP drug levels under the microscope: afamelanotide study completed

Disease control Completed

This study looked at how the drug afamelanotide (Scenesse) behaves in the bodies of 28 people with erythropoietic protoporphyria (EPP), a rare condition that causes severe pain on sun exposure. Researchers measured the drug's concentration in the blood after a single implant. The…

Phase: PHASE1, PHASE2 • Sponsor: Clinuvel Europe Limited • Aim: Disease control

Last updated Jul 29, 2026 00:00 UTC